Instil Bio, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Instil Bio, Inc. (TIL) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Instil Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $162.00K, a 75.15% decline year-over-year.
- Instil Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$1.53M.
- Instil Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.18M.
- Instil Bio, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $897.00K, a 82.22% decline year-over-year.
- Instil Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$6.12M, a 2866.97% decline from fiscal 2024.
- Instil Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $221.00K, a 8.30% decline from fiscal 2023.
- Instil Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $241.00K, a 43.95% decline from fiscal 2022.
- Instil Bio, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $430.00K, a 91.48% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.36M 10-Q · filed 2026-08-13 | -$2.55M derived: sum of 3 quarters · filed 2026-08-13 | -$1.65M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$1.53M 10-Q · filed 2026-05-15 | -$2.71M derived: sum of 2 quarters · filed 2026-05-15 | -$1.81M derived: sum of 3 quarters · filed 2026-05-15 | -$1.16M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$285.00K derived: sum of 2 quarters · filed 2026-03-27 | $367.00K derived: sum of 3 quarters · filed 2026-08-13 | -$6.12M 10-K · filed 2026-03-27 | |
| 2025-09-30 | $897.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.55M derived: sum of 2 quarters · filed 2026-08-13 | -$4.93M 10-Q · filed 2025-11-13 | -$7.25M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $652.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$5.83M 10-Q · filed 2026-08-13 | -$8.15M derived: sum of 3 quarters · filed 2026-08-13 | -$3.10M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$6.48M 10-Q · filed 2026-05-15 | -$8.80M derived: sum of 2 quarters · filed 2026-05-15 | -$3.76M derived: sum of 3 quarters · filed 2026-05-15 | -$4.92M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.73M derived: sum of 2 quarters · filed 2026-03-27 | $1.56M derived: sum of 3 quarters · filed 2026-03-27 | $221.00K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $5.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.88M derived: sum of 2 quarters · filed 2025-11-13 | $2.54M 10-Q · filed 2025-11-13 | $4.03M 10-Q · filed 2024-11-13 | $1.70M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$2.50M 10-Q · filed 2025-08-13 | -$3.35M derived: sum of 3 quarters · filed 2025-08-13 | -$3.76M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$1.34M 10-Q · filed 2025-05-13 | -$2.18M derived: sum of 2 quarters · filed 2025-05-13 | -$2.60M derived: sum of 3 quarters · filed 2025-05-13 | -$1.87M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$841.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$1.26M derived: sum of 2 quarters · filed 2025-03-04 | -$532.00K derived: sum of 3 quarters · filed 2025-03-04 | $241.00K 10-K · filed 2025-03-04 | |
| 2023-09-30 | -$419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $309.00K derived: sum of 2 quarters · filed 2024-11-13 | $1.08M 10-Q · filed 2024-11-13 | -$656.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $728.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.50M 10-Q · filed 2024-08-13 | -$237.00K derived: sum of 3 quarters · filed 2024-08-13 | -$2.68M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $773.00K 10-Q · filed 2024-05-10 | -$965.00K derived: sum of 2 quarters · filed 2024-05-10 | -$3.40M derived: sum of 3 quarters · filed 2024-05-10 | -$1.62M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$4.18M derived: sum of 2 quarters · filed 2024-03-21 | -$2.40M derived: sum of 3 quarters · filed 2024-03-21 | $430.00K 10-K · filed 2024-03-21 | |
| 2022-09-30 | -$2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$657.00K derived: sum of 2 quarters · filed 2023-11-13 | $2.17M 10-Q · filed 2023-11-13 | $4.34M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.61M 10-Q · filed 2023-08-14 | $6.78M derived: sum of 3 quarters · filed 2023-08-14 | $6.88M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $2.83M 10-Q · filed 2023-05-11 | $4.99M derived: sum of 2 quarters · filed 2023-05-11 | $5.09M derived: sum of 3 quarters · filed 2023-05-11 | $8.71M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.27M derived: sum of 2 quarters · filed 2023-03-31 | $5.88M derived: sum of 3 quarters · filed 2023-03-31 | $5.04M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.71M derived: sum of 2 quarters · filed 2022-11-14 | $2.88M 10-Q · filed 2022-11-14 | $3.78M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.78M 10-Q · filed 2022-08-12 | $3.68M derived: sum of 3 quarters · filed 2022-08-12 | $5.50M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$836.00K 10-Q · filed 2022-05-16 | $67.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.89M derived: sum of 3 quarters · filed 2022-05-16 | $1.99M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $2.73M derived: sum of 2 quarters · filed 2022-03-07 | $2.82M derived: sum of 3 quarters · filed 2022-03-07 | $898.00K 10-K · filed 2022-03-07 | |
| 2020-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.92M derived: sum of 2 quarters · filed 2021-11-15 | -$5.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.83M 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | -$1.92M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |